FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2606558932> ?p ?o ?g. }

• W2606558932 endingPage "52542" @default.
• W2606558932 startingPage "52527" @default.
• W2606558932 abstract "// Cheng Gong 1 , Jing Fang 2 , Guang Li 2 , Han-Han Liu 3 and Zhi-Su Liu 1 1 Department of General Surgery, Research Center of Digestive Diseases, Zhongnan Hospital of Wuhan University, Wuhan 430071, P.R. China 2 Department of Oncology, Wuhan Pu-Ai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430034, P.R. China 3 Department of Pathology, Maternal and Child Health Hospital of Hubei Province, Wuhan 430070, P.R. China Correspondence to: Han-Han Liu, email: hanhanl1010@163.com Zhi-Su Liu, email: zsliu53@126.com Keywords: microRNA-126, epidermal growth factor-like domain 7 (EGFL7), hepatocellular carcinoma, ERK signaling pathway, proliferation Received: October 12, 2016      Accepted: March 24, 2017      Published: April 20, 2017 ABSTRACT This study intends to explore the effects of microRNA-126 (miR-126) on cell proliferation, apoptosis, and tumor angiogenesis in hepatocellular carcinoma (HCC) by regulating epidermal growth factor-like domain 7 (EGFL7) through extracellular signal-regulated kinase (ERK) signaling. HCC tissues and adjacent normal tissues were obtained from 184 HCC patients. HCC cells were separately transfected with recombinant plasmids. Western blotting and qRT-PCR were applied to detect miR-126 and EGFL7, ERK, Fas/FasL, Bcl-2, Caspase mRNA and protein levels. CCK8 and TUNEL were performed to determinate cell proliferation and apoptosis. Flow cytometry was used to analyze cell cycle distribution. Rats model of HCC was constructed, and tumor weight and the number of new blood vessels were recorded after 3 weeks of tumor transplantation. Compared with the adjacent normal tissues, HCC tissues exhibited lower miR-126 expression, and higher EGFL7, and ERK mRNA and protein levels. Overexpression of miR-126 in HCC cell lines suppressed EGFL7, ERK, Bcl-2, and P-ERK, and increased apoptotic-associated proteins Fas/FasL and Caspase-3, and it inhibited cell proliferation and induced cell apoptosis. Overexpression of miR-126 in nude mice resulted in reduced tumor weight and less new blood vessels in tumors. The inhibition of miR-126 decreased cell apoptosis, and enhanced cell proliferation and tumor angiogenesis. This study demonstrates that miR-126 might decrease cell proliferation, induce apoptosis, and inhibit tumor angiogenesis in HCC by inhibiting EGFL7 via down-regulating the ERK signaling pathway." @default.
• W2606558932 created "2017-04-28" @default.
• W2606558932 creator A5045550508 @default.
• W2606558932 creator A5055328507 @default.
• W2606558932 creator A5068661721 @default.
• W2606558932 creator A5069088751 @default.
• W2606558932 creator A5077432577 @default.
• W2606558932 date "2017-04-20" @default.
• W2606558932 modified "2023-09-30" @default.
• W2606558932 title "Effects of microRNA-126 on cell proliferation, apoptosis and tumor angiogenesis via the down-regulating ERK signaling pathway by targeting EGFL7 in hepatocellular carcinoma" @default.
• W2606558932 cites W1484083850 @default.
• W2606558932 cites W1536340771 @default.
• W2606558932 cites W1554051124 @default.
• W2606558932 cites W1971276126 @default.
• W2606558932 cites W1990296937 @default.
• W2606558932 cites W1992710380 @default.
• W2606558932 cites W2002622232 @default.
• W2606558932 cites W2003371822 @default.
• W2606558932 cites W2008271972 @default.
• W2606558932 cites W2023250239 @default.
• W2606558932 cites W2032565321 @default.
• W2606558932 cites W2046623913 @default.
• W2606558932 cites W2046885677 @default.
• W2606558932 cites W2047098641 @default.
• W2606558932 cites W2069135380 @default.
• W2606558932 cites W2070388805 @default.
• W2606558932 cites W2071144156 @default.
• W2606558932 cites W2073748539 @default.
• W2606558932 cites W2079171870 @default.
• W2606558932 cites W2092315759 @default.
• W2606558932 cites W2103086537 @default.
• W2606558932 cites W2112681123 @default.
• W2606558932 cites W2124258353 @default.
• W2606558932 cites W2126850943 @default.
• W2606558932 cites W2128077526 @default.
• W2606558932 cites W2136625809 @default.
• W2606558932 cites W2149729293 @default.
• W2606558932 cites W2161039843 @default.
• W2606558932 cites W2168095422 @default.
• W2606558932 cites W2228600754 @default.
• W2606558932 cites W2324062027 @default.
• W2606558932 cites W2472322976 @default.
• W2606558932 cites W2514183797 @default.
• W2606558932 cites W3023299375 @default.
• W2606558932 cites W4211105405 @default.
• W2606558932 cites W59556011 @default.
• W2606558932 doi "https://doi.org/10.18632/oncotarget.17283" @default.
• W2606558932 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5581048" @default.
• W2606558932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28881749" @default.
• W2606558932 hasPublicationYear "2017" @default.
• W2606558932 type Work @default.
• W2606558932 sameAs 2606558932 @default.
• W2606558932 citedByCount "33" @default.
• W2606558932 countsByYear W26065589322017 @default.
• W2606558932 countsByYear W26065589322018 @default.
• W2606558932 countsByYear W26065589322019 @default.
• W2606558932 countsByYear W26065589322020 @default.
• W2606558932 countsByYear W26065589322021 @default.
• W2606558932 countsByYear W26065589322022 @default.
• W2606558932 countsByYear W26065589322023 @default.
• W2606558932 crossrefType "journal-article" @default.
• W2606558932 hasAuthorship W2606558932A5045550508 @default.
• W2606558932 hasAuthorship W2606558932A5055328507 @default.
• W2606558932 hasAuthorship W2606558932A5068661721 @default.
• W2606558932 hasAuthorship W2606558932A5069088751 @default.
• W2606558932 hasAuthorship W2606558932A5077432577 @default.
• W2606558932 hasBestOaLocation W26065589321 @default.
• W2606558932 hasConcept C104317684 @default.
• W2606558932 hasConcept C121608353 @default.
• W2606558932 hasConcept C126322002 @default.
• W2606558932 hasConcept C145059251 @default.
• W2606558932 hasConcept C190283241 @default.
• W2606558932 hasConcept C2778019345 @default.
• W2606558932 hasConcept C2780394083 @default.
• W2606558932 hasConcept C29537977 @default.
• W2606558932 hasConcept C502942594 @default.
• W2606558932 hasConcept C54355233 @default.
• W2606558932 hasConcept C55493867 @default.
• W2606558932 hasConcept C57074206 @default.
• W2606558932 hasConcept C62112901 @default.
• W2606558932 hasConcept C62478195 @default.
• W2606558932 hasConcept C71924100 @default.
• W2606558932 hasConcept C86803240 @default.
• W2606558932 hasConcept C95444343 @default.
• W2606558932 hasConceptScore W2606558932C104317684 @default.
• W2606558932 hasConceptScore W2606558932C121608353 @default.
• W2606558932 hasConceptScore W2606558932C126322002 @default.
• W2606558932 hasConceptScore W2606558932C145059251 @default.
• W2606558932 hasConceptScore W2606558932C190283241 @default.
• W2606558932 hasConceptScore W2606558932C2778019345 @default.
• W2606558932 hasConceptScore W2606558932C2780394083 @default.
• W2606558932 hasConceptScore W2606558932C29537977 @default.
• W2606558932 hasConceptScore W2606558932C502942594 @default.
• W2606558932 hasConceptScore W2606558932C54355233 @default.
• W2606558932 hasConceptScore W2606558932C55493867 @default.
• W2606558932 hasConceptScore W2606558932C57074206 @default.
• W2606558932 hasConceptScore W2606558932C62112901 @default.
• W2606558932 hasConceptScore W2606558932C62478195 @default.

• next